drugset / Trial / NCT00220896
Prevention of Postoperative Delirium With Donepezil
RandomizedParallel-groupDouble-blindPrevention
Summary
Patients undergoing hip or knee joint replacement at the age of 70 years or above who are cognitively unimpaired will receive donepezil or matching placebo before (over 5-7 days), during and after (over 7 days) surgery. The incidence of delirium will be monitored at 3 days, 7 days, and 49 days following surgery. We hypothesize that the incidence of delirium can be lowered from 20 per cent to 10 per cent by the intervention.
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | — | — |
Indications
No indication recorded.